PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Dec-2023 Integrative Medical Center Chain, Nava Health, Utilizes AI to Revolutionize Medical Documentation and Enhance Call Center Operations AccessWire
08-Dec-2023 Bionoid Pharma Inc. Provides Update on Binding Letter of Intent to Acquire Global Alerts Corp. AccessWire
08-Dec-2023 Updated clinical safety and efficacy data for iOnctura’s roginolisib presented at ESMO Immuno-Oncology Congress 2023 iOnctura
08-Dec-2023 TILT Biotherapeutics Announces Positive Clinical Data in Checkpoint Resistant Metastatic Melanoma Phase I Trial at ESMO Immuno-Oncology 2023 TILT Biotherapeutics
08-Dec-2023 Latest economic data underlines risk of disincentivising UK life sciences growth ABPI
08-Dec-2023 Medidata Unveils Multi-Sector Research Alliance at the 65th ASH Annual Meeting and Exposition Medidata
08-Dec-2023 Enhanced Protection for Manufacturing Highly Potent Pharmaceuticals Introduced at New Jersey Facility Experic
08-Dec-2023 FREEDOM HOLDINGS (FHLD) SHAREHOLDER UPDATE; 15c211 Nears Final Approval from FINRA  AccessWire
08-Dec-2023 Quest International and CLS America Forge Partnership to Accelerate Commercialization Efforts for the TRANBERG Laser Ablation System in US Market AccessWire
08-Dec-2023 ATTCS CALL FOR ACTION TO ASSURE THE FUTURE OF ADVANCE THERAPIES ADOPTION IN THE UK ATTCS
08-Dec-2023 Terumo Blood and Cell Technologies takes part in Connecting the Dots: a new film series showcasing the pivotal role of medical technologies to improve healthcare Terumo Blood and Cell Technologies
08-Dec-2023 PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023 PureTech
08-Dec-2023 BC Platforms Acquires Medexprim, Paving the Way for Global Leadership in Real-World Data and Real-World Evidence Analytics BC Platforms
08-Dec-2023 Aptar Pharma Continues Global Expansion Program with Opening of New Mumbai Site Aptar Pharma
08-Dec-2023 NHS releases latest mental health medicines statistics NHS Business Services Authority (NHSBSA)
08-Dec-2023 ABB launches ABB Ability™ Field Information Manager 3.0 to help future-proof industrial operations ABB
08-Dec-2023 Vesper Bio doses first volunteer in Phase I study of first-in-class oral treatment for Frontotemporal Dementia (FTD) Vesper Bio
08-Dec-2023 Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study Synaffix
08-Dec-2023 SpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01 SpyBiotech
08-Dec-2023 Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea Sosei Group